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Fasciola hepatica hijacks host 
macrophage miRNA machinery 
to modulate early innate immune 
responses
Nham Tran1,5, Alison Ricafrente2,5, Joyce To2, Maria Lund2, Tania M. Marques3, 
Margarida Gama‑Carvalho3, Krystyna Cwiklinski4, John P. Dalton4 & Sheila Donnelly2* 
Fasciola hepatica, a global worm parasite of humans and their livestock, regulates host innate 
immune responses within hours of infection. Host macrophages, essential to the first‑line defence 
mechanisms, are quickly restricted in their ability to initiate a classic protective pro‑inflammatory 
immune response. We found that macrophages from infected animals are enriched with parasite‑
derived micro(mi)RNAs. The most abundant of these miRNAs, fhe-miR-125b, is released by the 
parasite via exosomes and is homologous to a mammalian miRNA, hsa-miR-125b, that is known to 
regulate the activation of pro‑inflammatory M1 macrophages. We show that the parasite fhe-miR-
125b loads onto the mammalian Argonaut protein (Ago‑2) within macrophages during infection 
and, therefore, propose that it mimics host miR-125b to negatively regulate the production of 
inflammatory cytokines. The hijacking of the miRNA machinery controlling innate cell function could 
be a fundamental mechanism by which worm parasites disarm the early immune responses of their 
host to ensure successful infection.
Helminths, or worms, are multicellular parasites that can live for many years within their vertebrate hosts. Of 
prime importance is the regulation of the host immune cell signalling pathways to prevent the parasite’s elimi-
nation before they can produce their off-spring in the form of eggs. Many worm parasites inactivate innate cell 
detection systems, such as macrophage and dendritic inflammatory responses, and direct the adaptive immune 
response towards a tolerant or hyporesponsive  state1–4. Understanding how worm parasites do this will inform 
the design of new anti-helminthic treatments, such as drugs or vaccines.
Fasciola hepatica, or liver fluke, is a global zoonotic food-borne parasite that infects humans and their live-
stock. The parasite is one of the most successful helminths as it is found on every inhabited continent and infects 
the widest variety of mammalian hosts infected by any worm, including some that it has encountered only in 
relatively recent times (e.g. camelids and marsupials)5,6. This implies a superior adaptation to the mammalian 
host and suggests that F. hepatica parasites have evolved a universal process of invasion, tissue migration and 
immune modulation.
Mammalian hosts become infected with F. hepatica following ingestion of vegetation contaminated with 
encysted parasites (metacercariae). Within the intestine, juvenile parasites emerge from their cysts (termed 
newly excysted juveniles, NEJ) and within ~ 2 to 6 h traverse the intestinal wall and enter the peritoneal cavity. 
During the next 2–3 days of infection they rely on stored glycogen resources to migrate from the peritoneal cav-
ity into the liver parenchyma where they begin to rapidly grow and develop. Their migratory activity in the liver 
causes the extensive haemorrhaging and tissue destruction associated with acute disease. During the invasion 
and pre-hepatic migratory stage, animals display no clinical signs of infection, and, histologically, no significant 
inflammatory changes are observed in the intestinal wall or peritoneal  cavity7,8. This suggested that the parasites 
employ a mechanism(s) to disarm the host’s innate ‘early-response’ immune system to prevent their detection 
at a vulnerable time in their invasion.
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Within the peritoneal cavity macrophages are the primary immune cell contributing to the immediate 
response to invading  pathogens9 and are the predominant innate immune cell present during the first days of 
infection with F. hepatica10,11. Macrophages are major regulators of the inflammatory response as they monitor 
blood and tissues for signs of infection or damage and alert adaptive immune cells to any incursions. In response 
to invading pathogens, macrophages are typically ‘classically activated’ by signals from the pathogen itself and 
from damaged host tissue. This ‘M1’ phenotype of macrophage displays enhanced phagocytic and antigen pres-
entation capacity and drives host protective immune responses by producing pro-inflammatory cytokines (such 
as TNF, IL-6 and IL-12) and anti-microbial effector molecules (like nitric oxide; NO)12. Despite the presence of 
migrating F. hepatica parasites, the levels of NO produced by peritoneal macrophages isolated from infected sheep 
are the same as macrophages from uninfected  sheep10,13. Furthermore, peritoneal macrophages from infected 
sheep show no significant increase in the expression levels of pro-inflammatory cytokines (TNF, IL-12, IFNγ, 
iNOS)14. Importantly, this modulation of pro-inflammatory immune responses is also evident in experimental 
infections in  mice15–17. The absence of a classical host protective inflammatory response to invading F. hepatica 
implies that the parasite possesses an effective mechanism of control on macrophage activity.
Helminth parasites secrete a range of soluble proteins/glycans that have been shown to suppress the ability 
of host macrophages to differentiate to M1  phenotype18–20. More recently, a role for miRNAs in the regulation of 
host immune responses by parasitic worms has been  suggested21–23. Comparative analysis of parasite genomes has 
shown that some helminth miRNAs are widely conserved while others are specific to particular  helminths24,25. 
Moreover, a number of the conserved miRNAs share sequence identity with mammalian miRNAs that are known 
to have an immune regulatory function. Target prediction software suggests that helminth miRNAs may act to 
regulate host immune responses to enable their development and  survival21–23. However, to date, the evidence 
to support this proposed miRNA-mediated mechanism of immune modulation has come from in vitro analysis 
of transfected  cells26,27 or the identification of parasite miRNAs in sera or tissue of infected  hosts28–30. Here we 
show that F. hepatica releases miRNAs, that are homologous to host miRNAs, that regulate macrophage function 
in vivo and propose that worms may hijack this process to control their host’s early immune responses.
Results
Parasite‑derived miRNAs are located within macrophages during infection with Fasciola 
hepatica. To investigate whether miRNAs produced by F. hepatica contributed to the inhibition of mac-
rophage activation in early infection, we orally infected BALB/c mice with F. hepatica metacercariae and searched 
for parasite miRNAs in peritoneal macrophages at selected time-points (6 h, 12 h, 24 h, 3 days and 5 days after 
infection) using RNASeq (deposited in NCBI’s GeneExpression Omnibus; accession number GSE145597; 
https:// www. ncbi. nlm. nih. gov/ geo/ query/ acc. cgi? acc= GSE14 5597). After first cleaning the datasets obtained, 
reads were mapped against the mouse database from miRBase (mmu). Then, to identify F. hepatica-specific 
miRNAs the remaining 15,796,193 reads were screened against the miRBase list of 30 F. hepatica  miRNAs31. 
Using this approach, we identified 10 F. hepatica miRNAs that were present within peritoneal macrophages 
of infected mice (Table 1). F. hepatica miR-125b (fhe-miR-125b) was the most abundant miRNA observed in 
peritoneal macrophages during the first 24 h of infection, with expression peaking at approximately 12 h after 
infection. This is coincident with the migration of NEJs through the intestine and into the peritoneal cavity, and 
also with the observed early suppression of host innate immune responses, as described  above10,13,14. This rapid 
and transient expression pattern of fhe-miR-125b in peritoneal macrophages was corroborated by RT-qPCR 
(Fig. 1a). Consistent with these observations, the expression of fhe-miR-125b was also observed in peritoneal 
cells isolated from sheep after an experimental infection with 150 metacercariae (Fig. 1b). These miRNAs were 
not detected in peritoneal macrophages taken from non-infected mice or sheep (Fig. 1a,b).
To verify that the primers were specifically detecting a miRNA of parasite origin, infectious metacercaraie 
were experimentally excysted in vitro and the RNA of the emerging newly excysted juvenile (NEJ) subjected to 
Table 1.  Read numbers of known Fasciola hepatica miRNAs detected by miRNASeq in peritoneal 
macrophages harvested from infected mice over a time-course of 5 days. a Two biological samples were 




Uninfecta 6 h 12 h 24 h 3 days 5 days
fhe-bantam –b – 2 1 – – 1 – – – – –
fhe-miR-125b – – 1 16 6 16 1 2 – 1 – –
fhe-miR-36a – – 1 – – – – – – – – –
fhe-miR-61 – – – 3 1 5 – 3 – – – –
fhe-miR-125a – – – 1 – – – – – – – –
fhe-miR-46 – – – 1 – 1 – – – – – –
fhe-miR-277 – – – 2 – 3 – – – – – –
fhe-miR-10 – – – 1 – – – – – – – –
fhe-miR-219 – – – – 1 1 – – – – – –
fhe-miR-71b – – – – – 1 – – – – – –
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RT-qPCR. This confirmed that fhe-miR-125b is expressed by the NEJ parasites (Fig. 1c). RT-qPCR also demon-
strated that miR-125b could be amplified from RNA isolated from Schistosoma mansoni, a trematode parasite 
like F. hepatica, but not from the free-living nematode Caenorhabditis elegans. This result concurs with reports 
demonstrating that the expression of a miR-125b is specific to trematode  parasites32. Comparison of the expres-
sion of fhe-miR-125b across the different intra-mammalian life-stages of F. hepatica revealed strict temporal 
expression, supporting the idea that worm miRNAs govern developmental processes. In the context of a role in 
the immune modulation of innate immune responses after infection, it was notable that the expression of fhe-
miR-125b was most abundant in NEJs, the stage that initiate infection.
Several studies suggest that extracellular vesicles (EVs) are the main reservoir of exogenous miRNAs. In this 
study, EVs were harvested from in vitro cultured NEJs and shown to contain fhe-miR-125b (Fig. 1d). Since EVs 
released during helminth infections are primarily taken up by  macrophages26,27 this provides a mechanism by 
which fhe-miR-125b and other miRNAs are delivered into the macrophages.
Fasciola hepatica miR-125b targets innate immune signalling pathways. The secondary struc-
ture of fhe-miR-125b indicates a typical miRNA with the mature strand located on the 5′ arm of the precursor 
(Fig. 2a). Previous studies have documented human hsa-miR-125b as a miRNA that regulates the inflammatory 
response of macrophages by controlling the activation of M1  macrophages33–35. Using a phylogenetic approach, 
we compared the structure of fhe-miR-125b to its human homologue and to miR-125 sequences from the closely 
related trematodes, Schistosoma japonicum and mansoni (Fig. 2b). This analysis revealed that miR-125b in Fas-
ciola is closely related to the human miRNA, but is distinct from miR-125b found in the Schistosome parasites. 
This may suggest fhe-miR-125b could target the same host genes as hsa-miR-125b and thus play a significant role 
in the control of host immune responses during early infection.
To address this possibility experimentally, a list of putative cellular targets for mature fhe-miR-125b, (CCC 
CUG AGA CUG AUA AUU GCUC) was initially generated using the online miRNA target prediction tool miRDB 
(https:// mirdb. org). Only those genes assigned a target score > 60 (a predictive score generated by  MirTarget36) 
were regarded as authentic and selected for further analysis. The resultant 511 genes (Supplementary Table 1) 
were mapped for protein–protein interactions using the innate immune data reference  set37 and provided 798 
immune-related protein–protein interactions with an enrichment in the nucleus (Fig. 2c). This dataset was then 
filtered down to cell specific associations restricted to peritoneal macrophages. Surprisingly, from this analysis, 
only two gene targets emerged; Traf6 and Nlrc5. Pathway analysis of the interactions showed that Traf6-mediated 
events were over-represented (Fig. 2e). To further scrutinise if Traf6 could be the prime target candidate for fhe-
miR-125b, two additional predictive tools were then used, miRanda and TargetScan (Supplementary Table 1). 
Supporting the miRDB initial analysis, TRAF6 was one of only 43 genes that were commonly predicted as targets 
for fhe-miR-125b by all three tools. Furthermore, the significant reduction in the expression of TRAF6 in peri-
toneal macrophages harvested from mice at the same timepoints that fhe-miR-125b is most abundant (Fig. 2f), 
provides experimental evidence to validate the predictive analysis. As a transcription factor that is central to 
Figure 1.  Worm-derived miRNA fhe-miR125b is detected within the peritoneal macrophages of mice and 
sheep infected with Fasciola hepatica. The presence of worm fhe-miR125b was (a) validated in the peritoneal 
macrophages that had been harvested from mice at 0 h, 6 h, 12 h and 72 h after an oral infection with 20 F. 
hepatica metacercariae and subjected to small RNA sequence analysis; and examined in (b) peritoneal cells 
harvested from uninfected sheep and from sheep at 2 and 9 days after an oral infection with 150 metacercariae. 
(c) The expression of fhe-miR125b was measured in RNA extracted from the F. hepatica newly excysted juveniles 
(NEJ), 21-day old worms (immature) and adult worms and compared to expression levels in adult (male and 
female mixed population) Schistosoma mansoni and Caenorhabditis elegans. (d) RT-qPCR using primers specific 
for fhe-miR125b was carried out on RNA extracted from NEJ extracellular vesicles (EVs). In these experiments, 
levels of fhe-miR125b expression determined by RT-qPCR are represented as the starting quantity of genetic 
material prior to amplification (N0) as determined by LinRegPCR (v.11). The data is presented as the mean ± SD 
of triplicate biological samples.
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a number of immune signalling pathways, TRAF6 is regarded as an indispensable regulator of inflammatory 
 responses38. Indeed, gene ontology analysis of the predicted gene target list conducted against a Mus musculus 
background using GO tool DAVID (http:// david-d. ncifc rf. org) identified major signalling pathways known to 
control innate inflammatory responses (MAPK signalling, TNF signalling, NOD-like receptor signalling) within 
the top ten generated target KEGG  pathways39 (Fig. 2d and Supplementary Table 2) thus providing more evidence 
for a role for fhe-miR-125b in the regulation of immune responses.
A central role for fhe-miR-125b in the regulation of these signalling pathways was also corroborated by expres-
sion profiling of macrophages harvested from the peritoneal cavity of mice 18 h after an oral infection with F. 
hepatica. Of the 610 genes that were identified to be significantly (p > 0.05) downregulated (> twofold change in 
expression), a large number of these were pro-inflammatory/innate cytokines and chemokines or transcription 
factors that regulate cytokine-signalling pathways (Supplementary Table 3). This is illustrated in the global KEGG 
analysis of these genes which created a profile suggesting involvement predominantly in MAPK, JAK-STAT, TNF 
and TLR signalling (Supplementary Fig. 1) and which was almost identical to that predicted for fhe-miR125b 
using GO tool DAVID above (Fig. 2).
To provide experimental proof of the ability of fhe-miR-125b to directly engage in the regulation of pro-
inflammatory pathways in macrophages, primary murine macrophages were transfected with synthetic versions 
of both the F. hepatica and human miR-125b. While neither miRNA had any apparent effect on macrophages 
when transfected under basal culturing conditions, both transfections significantly inhibited the ability of mac-
rophages to express TRAF6 in response to a challenge with bacterial LPS (Fig. 3a) and, as a consequence, the pro-
duction of both IL-6 and TNF were significantly reduced (Fig. 3b,c). This outcome was specific to the miR-125b 
as transfection with a scrambled non-targeting miRNA had no effect. We propose, therefore, that the F. hepatica 
fhe-miR-125b, like its mammalian counterpart, functions to regulate the ability of macrophages to respond to 
pro-inflammatory signalling, thus preventing the differentiation to an M1 phenotype.
Fasciola hepatica miR-125b complexes with the mammalian Argonaute‑2 protein in host mac‑
rophages to regulate mammalian gene expression. The mechanism(s) by which the exogenous 
worm miRNAs operate in mammalian immune cells to alter their function remains enigmatic. However, studies 
in mammalian cells have shown that in the first step miRNAs must form a complex with an Argonaute protein 
(Ago). This Ago-miRNA association forms the core of the miRNA-induced silencing complex (miRISC), which 
is then guided by the complexed miRNA to bind complementary (target) sequences in the messenger RNA 
(mRNA)40. Helminth Ago proteins have been detected within secreted EVs and may be involved in the regula-
tion of mammalian target  genes26. However, given the similarity of fhe-miR-125b to its mammalian homolog we 
surmised that helminth miRNAs delivered into immune cells could directly load onto mammalian Ago2. In this 
way worm miRNAs would compete with the mammalian miRNA machinery to influence host gene expression. 
To test this idea, murine Ago2 was isolated by immunoprecipitation from the peritoneal macrophages taken 
from infected mice at 6 h and 12 h post infection (IP; Supplementary Fig. 2) and the miRNA extracted and sub-
jected to RT-qPCR. We used the detection of murine miR-21 as a control for the pulldown and to demonstrate 
the normalisation of input miRNA to the RT-qPCR. This miRNA has been characterised as a central regulator of 
macrophage activity and its expression is enhanced by inflammatory  stimuli41–43. Therefore, the observation of 
this murine miRNA loaded onto the Ago-2 within peritoneal macrophages of infected mice at both 6 h and 12 h, 
but not in uninfected animals (Fig. 3d) supports the efficacy of the pulldowns and validates the normalisation 
of miRNA input to the RT-qPCR. In contrast, the parasite-derived mir-125 was loaded onto Ago-2 only at 12 h 
timepoint (a time when fhe-miR-125b expression was at its peak; Table 1) reflecting the changes to the loading of 
mir-125b as a result of the progression of parasite infection (Fig. 3d).
Discussion
On invasion of the host by the parasite F. hepatica protective pro-inflammatory cytokine expression in mac-
rophages is quickly blocked. Thus, a major player in the innate cell immune system is inactivated at a stage 
when the parasite is most vulnerable and depends on its glycogen stores for energy to power its way from the 
intestine to the liver. Our study suggests that this trematode parasite, and perhaps others, exploit homologs of 
the immune-regulatory miRNAs of the host to hijack macrophage signalling pathways to disarm their function.
Figure 2.  TRAF6 is the primary gene predicted as a target for fhe-miR125b in peritoneal macrophages. (a) 
The hairpin structure of fhe-miR125b, produced by RNAfold (http:// rna. tbi. univie. ac. at/ cgi- bin/ RNAWe bSuite/ 
RNAfo ld. cgi) (b) Phylogram of miR125 generated using T-Coffee (http:// tcoff ee. crg. cat), based on the hairpin 
structures. (c) Illustration of a Protein–Protein Interaction map for the 798 immune-related genes predicted 
from gene target analysis (created by Innate DB; https:// www. innat edb. com). Of these, the nucleus showed the 
highest number of interactions account for greater than 50% of all the interactions. (d) GO analysis of pathways 
represented by the predicted gene targets for fhe-miR-125b, produced using bioconductor (https:// www. bioco 
nduct or. org). (e) Mapping predicted gene targets to a mouse interactome produced 66 nodes (image created by 
Innate DB; https:// www. innat edb. com). Within these, Traf6 (red box) mapped to 35–40% of the nodes (Blue 
dots). All other nodes not connected to Traf6 are shown in yellow and red. A detailed map of these interactions 
can be viewed in supplementary Fig. 3. (f) The expression of TRAF6 was measured in RNA extracted from 
peritoneal macrophages harvested from uninfected mice (Uninf) or from mice at 6 h and 12 h after an oral 
infection with F. hepatica. The level of expression is represented as the starting quantity of genetic material 
prior to amplification (N0) as determined by LinRegPCR (v.11). The data is representative of three independent 
experiments and is presented as the mean ± SD of triplicate biological samples. The data was analyzed using one-
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Several parasitic worm miRNAs share homology with mammalian miRNAs. Thus, they have the capacity to 
regulate the expression of an array of host genes within macrophages and other innate cells to effectively evade 
expulsion and continue their growth and development to maturity. Our gene target analysis and in vitro stud-
ies pinpoint a specific mechanism whereby F. hepatica could interrupt the MAPK signalling pathway of innate 
immune responses via the regulation of TRAF6 by fhe-miR-125b. This mechanism is supported by the presence 
of a single miR-125b binding site on the 3′ UTR of  TRAF644. The identification of mammalian genes and immune 
pathways targeted by parasite miRNAs has major implications for our understanding of the interaction between 
parasite and host.
It is highly significant that miR-125b, the most predominant parasite miRNA found in host macrophages 
of mice infected with F. hepatica, is conserved amongst the trematode clade of helminths, including the blood 
flukes of the genus Schistosoma, as it points towards a common mechanism for the anti-inflammatory control 
amongst these important parasites of humans and their livestock. Indeed, recent studies have shown that the 
miR-125b orthologue is highly enriched in EVs released by S. mansoni and S. japonicum, representing 40% and 
65% respectively of the total miRNA  reads27,45. However, in contrast to the immune modulatory effect of fhe-
miR-125b we have shown here, transfection of murine macrophages with sja-miR-125b resulted in the induction 
of pro-inflammatory immune responses as assessed by an increased production of  TNF27. Predictive analysis 
of this parasite miRNA led Liu et al.27 to suggest that the sja-miR-125b was targeting the expression of Pros1, a 
gene known to inhibit TLR-driven pro-inflammatory responses. Neither of the three predictive tools used in our 
study, predicted this gene as a target for the F. hepatica miR-125b, nor was it identified amongst the genes down-
regulated in macrophages isolated from infected mice. These contrasting observations could suggest that miR-
125b plays different functions for different parasites. Unlike F. hepatica, a pro-inflammatory Th1-type immune 
response dominates during the first 3–5 weeks of infection with Schistosome parasites. As the parasites mature 
and females become fecund, parasite eggs trapped in tissues induce potent Th2 responses that suppress Th1 
 responses46. The sja-miR-125b was identified within EVs isolated from parasites collected from mice at 28 days 
post-infection27, a pre-patent time point, coincident with a strong Th1 pro-inflammatory immune response.
A single miRNA can influence the expression of a multitude of different genes. mRNA silencing efficiency is 
determined by the sequence of the seed region, free energy produced by the miRNA-target duplex and stabil-
ity of the miRNA 5′ terminal and seed  region47. While high specificity of the miRNA seed sequence has been 
largely reported as the crucial factor to miRNA target recognition, nucleotide pairings outside of the seed are 
also known to affect gene target recognition and overall thermodynamic stability of the miRNA-target  duplex48. 
These key concepts are integrated in predictive tools such as miRDB and MiRanda that scrutinise whole mature 
miRNA sequences. Examining the overall structure of miR-125 from various species, phylogenetic analysis 
indicates that fhe-miR-125b is closely related to its human counterpart and distal to that of miR-125b found in 
Schistosome. This may explain why Pros1 was not predicted to be a target for fhe-miR-125b and only regulated 
by sja-miR-125b. It would be interesting to determine which exact nucleotides outside the seed region may 
account for this specificity.
miRNAs are not functional until they are loaded onto an Ago protein, a process that facilitates base-pairing 
to mRNA targets and ultimately translational repression and mRNA degradation. Here we provide proof that 
exogenous, worm-derived miRNA is delivered into macrophages, probably via exosomes, during infection and 
loads onto host Ago2. Coupled with our in vitro transfection studies that shows fhe-miR-125b can alter mac-
rophage phenotype we can deduce that parasite miRNAs are functional within mammalian cells. We have to 
assume that this binding mimics that of host hsa-miR-125b and, therefore, operates in the same way, to regulate 
the pro-inflammatory response of  macrophages33–35.
It has been reported that miRNAs that have homologs in mammalian hosts dominate the miRNA cargo of F. 
hepatica EVs. However, a number of miRNAs which are novel to the parasite have also been identified here and 
 elsewhere23. Predictive analysis suggests that these too have the capacity to regulate immune-related mammalian 
 genes23,25. As the loading of miRNAs to Ago protein is a very precise process with the requisite thermodynam-
ics and base-match composition, it remains to be determined whether homology to a mammalian miRNA is 
essential for a parasite miRNA to associate with mammalian Ago and annex the mammalian miRNA machinery.
The ability of F. hepatica to invade, infect and produce progeny in a very broad range of species indicates a 
strong universal compatibility between the parasite and its mammalian host, particularly in terms of attuning 
the immune response. This study provides direct in vitro and in vivo evidence for the role of helminth-derived 
Figure 3.  TRAF6 signaling and downstream production of IL-6 and TNF by macrophages is suppressed by fhe-
miR-125b by binding the mammalian argonaute protein-2. Bone marrow derived macrophages were transfected 
with the parasite-derived fhe-miR-125b, the human miR-125b or a scrambled miRNA (20 nM) and stimulated 
24 h later with bacterial lipopolysaccharide (LPS; 10 ng/ml) for 6 h. (a) The expression of TRAF6 was measured 
using RT-PCR and is presented the fold change in expression as compared to the LPS stimulated cells. The data 
is the mean ± SD of three independent experiments, each with biological triplicate samples. (b) The quantity of 
TNF and (c) IL-6 secreted by the macrophages into culture medium was measured by ELISA. The data shown is 
the mean ± SD of two independent experiments, each with biological triplicate samples. (d) Argonaute(Ago)-2 
proteins were pulled down from extracted murine peritoneal macrophages pooled from five uninfected BALB/c 
mice (n = 3 pooled samples) and from five mice (n = 3 pooled samples) at 6 h and 12 h post-infection with F. 
hepatica. Ago-2-bound RNA was extracted and analysed using RT-qPCR with primers specific for fhe-miR-125b. 
The quantity of miRNA detected is presented as the starting quantity of genetic material prior to amplification 
(N0) as determined by LinRegPCR (v.11). Statistical significance was determined by one-way analysis of 












Scientific Reports |         (2021) 11:6712  | https://doi.org/10.1038/s41598-021-86125-1
www.nature.com/scientificreports/
miRNAs in this complex parasite-host immune-interplay. Further elucidation of how mechanisms of immune 
modulation, involving nucleic acids, proteins and glycans, are employed by the parasite, especially during the 
early stage of infection, is critical for development of effective anti-helminth therapies to prevent infection and 
pathogenesis.
Methods
Murine and sheep infections. Six to eight week old female BALB/c mice (Australian Resource Centre, 
Perth, Australia) were orally infected with 20 metacercariae of F. hepatica (Baldwin Aquatics Inc, USA). Peri-
toneal exudate cells were collected by washing the peritoneal cavity with 5 ml of sterile saline. Ethical approval 
for this study was granted by the University of Technology Sydney (UTS) Animal Care and Ethics Committee 
(Approval Number: 2012-080) and experiments were conducted in accordance with the approved guidelines to 
be compliant with The Australian Code for the Care and Use of Animals for Scientific Purposes.
Ten 6 month-old male Dorset cross sheep (UK) were orally infected with 150 F. hepatica metacercariae (South 
Gloucester isolate, Ridgeway Research Ltd) administered in water. Animals were euthanized at selected time 
points post infection by captive bolt and peritoneal cells harvested as previously  described14. These experimental 
procedures were reviewed and approved by the Agri-Food Biosciences Institute (AFBI) Animal Ethics Com-
mittee, Northern Ireland, UK and carried out in accordance with the conditions of the operating license issued 
from the Department of Health, Social Services and Public UK by the Animal (Scientific Procedures) Act 1986 
(License No. PPL 2771). All animal work was performed and reported according to the ARRIVE guidelines.
Preparation of murine macrophages. Peritoneal macrophages were separated from the complete exu-
date cell population by negative selection using magnetic beads in accordance with the manufacturer’s instruc-
tions (Miltenyi, USA). Bone marrow cells isolated from BALB/c mice were differentiated for 6 days in RPMI 
1640 supplemented with FBS (10%v/v) and recombinant M-CSF (50 ng/ml; eBioscience, San Diego, CA, USA).
Small RNA library preparation and bioinformatics analysis. The quality of the raw fastq files was 
assessed using FastQC and the adapters were removed using Cutadapt v1.13. The sequences with length smaller 
that 18 bp were discarded also using Cutadapt. The reads were then pre-processed with an in-house perl script 
that filters homopolymers, sequences that contain Ns and low quality reads. The mature miRNA sequences of 
Mus musculus were retrieved from miRbase and used to build the index for the alignment using bowtie. After 
the pre-processing, the reads were aligned against the mouse mature miRNAs. The reads that did not align 
against the mouse mature miRNAs were aligned against the F. hepatica known miRNAs. After the alignments, 
another in-house script was used to count the reads that were successfully mapped.
Preparation of parasite RNA. Fasciola hepatica metacercariae were sourced from Ridgeway Research 
Ltd, UK. The South Gloucester isolate was used to infect sheep which allowed the recovery of adult worms from 
the bile ducts. BALB/c mice aged 6–8 weeks were orally infected with 30 metacercariae of F. hepatica (Italian 
isolate, Ridgeway Research Ltd) to recover the 21 day old immature flukes. All animal experimental procedures 
were carried out at Queen’s University Belfast, UK under license from the Home Office by the Animal (Scientific 
Procedures) Act 1986 (License No. PPL/2806) after ethical review by the Queen’s University Belfast Animal Wel-
fare and Ethical Review Body. The Italian isolate was also used for the excystment of newly excysted juveniles 
(NEJ)49 and parasite culture for the recovery of extracellular vesicles (EVs)50. Total RNA from all parasites stages 
(NEJ, NEJ EV, immature and adult worms) was extracted using the miRNeasy Mini Kit (Qiagen) according to 
the manufacturer’s instructions, eluted in 30 μl RNase-free water.
Caenorhabditis elegans were maintained in 35 mm diameter petri dishes containing Nematode Growth 
Medium agar, (3 g NaCl, 17 g agar, 2.5 g peptone, 1 mL 1 M  CaCl2, 1 mL 5 mg/mL cholesterol in ethanol, 1 ml 
1 M  MgSO4, 25 ml 1 M  KPO4 buffer [pH 6.0, 108.3 g  KH2PO4, 35.6 g  K2HPO4,  H2O to 1 L]) seeded with a lawn 
of Escherichia coli OP50. After 3–4 days, when all life stages of worms were present (embryo, larvae stages 1–4, 
and adult), worms were sub-cultured into new plates containing NGM agar and E. coli OP50. Once adequate 
numbers were achieved, worms were harvested by washing petri dishes with S buffer (129 mL 0.05 M  KH2PO4, 
871 mL 0.05 M  KH2PO4, and 5.85 g NaCl), and scraped off agar with a sterile glass rod. The worm suspension 
was then centrifuged at 1000×g for 5 min, and the pellet containing the worms washed with sterile PBS. The final 
worm pellet was resuspended in 1 mL RNAzol RT (Molecular Research Centre Inc, USA) and homogenised with 
mortar and pestle for RNA extraction.
Adult males and female S. mansoni worms (n = 166) in RNAlater stabilisation solution (Life Technologies, 
USA) was kindly donated by Prof. Donald McManus (Queensland Institute of Medical Research). Worms were 
washed with sterile PBS to remove RNAlater by centrifugation at 1000×g for 5 min at 4 °C. The final worm pellet 
was resuspended in 2 mL of RNAzol RT and homogenised with mortar and pestle for RNA extraction.
Preparation of macrophage extracellular vesicles. RAW 264.7 macrophages were cultured to conflu-
ency in RPMI + 10% FBS (v/v) at 37 °C and 5%  CO2. Cells were collected by scraping and cellular debris removed 
by sequential centrifugation steps of 2000×g for 20 min at 4 °C followed by 10,000×g for 30 min at 4 °C. To 
obtain the extracellular vesicles the supernatant was subjected to ultracentrifugation at 104,492×g for 2 h at 4 °C 
and the pelleted material re-suspended to maximum volume depending on the size of the centrifuge tube. This 
resuspension was then ultracentrifuged at 104,492×g overnight at 4 °C to separate the soluble proteins (now in 
the supernatant) and vesicles (now in the pellet).
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miRNA target prediction. To determine possible gene targets of selected F. hepatica miRNA, the miRNA 
sequence of fhe-miR-125b was initially analysed using custom prediction with a murine background on the 
online miRNA target prediction tool, miRDB (mirdb.org). Additionally, mouse mRNA 3′UTR sequences were 
analysed for fhe-miR-125b target pairing using miRNA target predictive tools miRanda (http:// www. micro rna. 
org/) and TargetScan (http:// www. targe tscan. org). miRNA:mRNA pairings with a target score of > 60 were con-
sidered in miRDB, target score > 155 and minimum free energy (MFE) < − 20 (Energy-Kcal/Mol) were consid-
ered in miRanda, and a seed sequence match of 7mer-m8 site in TargetScan. Only common genes determined 
by all predictive tools were considered for further analysis. The acquired list of gene targets was analysed using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (david.ncifcrf.gov) and sig-
nificant pathways targeted by fhe-miR-125a were determined using the murine Kyoto Encyclopaedia of Genes 
and Genomes (KEGG)  database39.
Microarray analysis. Microarray analyses were performed using the Illumina whole genome microarray 
platform (Illumina, USA) as previously  described51. Quality control of data was performed using GenomeStudio 
(version 1.1.1, Illumina) by examining intensity histograms of hybridisation efficiency and noise. GeneSpring 
GX version 11 (Agilent Technologies, Foster City, USA) was used for all subsequent data analyses. All data were 
entered into GeneSpring GX 11 and normalised to the 75th percentile. Data for each replicate were normalised 
to respective uninfected controls and filtered for significance on the basis of detection score, a GenomeStudio 
generated measure of signal intensity relative to background. At least half of all hybridisations had to have a 
detection score > 0.949, (which equates to a confidence value of p ≤ 0.05) for a gene to be accepted. Gene expres-
sion values for commonly up- and down-regulated genes were averaged and a Students t-test was performed to 
identify significant changes in gene expression compared with controls (p ≤ 0.05). An additional cut-off of ± two-
fold change in expression was applied to identify changes in gene expression with likely biological significance.
Transfection of bone marrow derived murine macrophages. Bone marrow derived macrophages 
(1 ×  106 cells/500 µl) were transfected with synthetic miRNAs (20 nM; (IDT, USA) combined with Lipofectamine 
RNAiMAX (Life Technologies, USA) over a period of 24 h in accordance to manufacturer’s protocol. Trans-
fected cells were washed with sterile PBS before stimulation with E. coli lipopolysaccharide (LPS; 10 ng/ml) 
for 6 h at 37 °C and 5%  CO2 to induce an inflammatory response. Non-transfected cells, and cells treated with 
Lipofectamine RNAiMAX alone, without LPS stimulation, were also analysed to control for contamination and 
possible immune responses induced by transfection reagents. Non-transfected cells were stimulated with LPS 
to determine the baseline inflammatory response of cultured macrophages. After LPS stimulation, the culture 
media was collected from all treatment groups for cytokine assays, and the cells washed with sterile PBS and 
collected for RNA extraction.
RNA extraction from mammalian cells. Cells or extracellular vesicles were homogenised with the 
RNAzol RT at 1 mL to  107 cells. Ultrapure DNAse/RNase free distilled water  (dH2O) (Life Technologies, USA) 
was added to the homogenate, at 0.4 mL of  dH2O per 1 mL of RNAzol RT used, and then centrifuged at 12,000×g 
for 15 min at 4 °C, to pellet DNA, proteins, and polysaccharides. Supernatant containing soluble RNA was col-
lected and combined with 4-bromoanisole (BAN; Sigma-Aldrich, USA) at 0.5% of supernatant volume, and then 
centrifuged at 12,000×g for 10 min at 4 °C to pellet residual DNA, proteins, and polysaccharides. To precipitate 
RNA, the supernatant was collected and combined with isopropanol (100% v/v; Sigma-Aldrich, USA) and 5 
μL glycogen (5 mg/mL; Life Technologies, USA), and incubated overnight at − 20 °C. The RNA precipitate was 
pelleted by centrifugation at 12,000×g for 10 min at 4 °C, washed with 500 µL ethanol (75% v/v; Sigma-Aldrich, 
USA) twice and re-solubilised in 25 µL  dH2O. Concentrations and quality of isolated RNA was measured using 
the NanoDrop One/One UV–Vis spectrophotometer (Life Technologies).
Pull‑down of argonaute‑2 (Ago‑2)‑bound miRNA from peritoneal macrophages. Peritoneal 
macrophages were collected and pooled from five uninfected or infected mice for Ago2 pulldown using the 
MagCapture microRNA isolation kit specific for mouse Ago-2 (FUJIFILM Wako Pure Chemical, JPN) accord-
ing to manufacturer’s instructions. Briefly, cleared cell lysate from each pooled sample of 2 ×  106 macrophages 
was incubated with AntiMouse Ago2 magnetic beads for 2 h at 4 °C with rotation. The beads were then washed 
and subjected to Proteinase K digestion. RNA was isolated from the digest using RNAzol RT and quantified 
using Qubit Fluorometer with a microRNA Assay kit (ThermoFisher Scientific). The miRNA samples were then 
normalised to a concentration of 0.5 ng/sample for RT-qPCR. This two-step normalisation of cell number and 
input miRNA ensured that all samples contained similar amounts of miRNA for comparable analysis by RT-
qPCR.
RT‑qPCR. After extraction of RNA, all samples were normalised to 100  ng/μL prior to cDNA synthesis. 
cDNA synthesis was carried out using the TaqMan MicroRNA Reverse Transcription Kit (Life Technologies, 
USA) according to manufacturer’s instructions. Synthesised cDNA was further diluted 1:4  dH2O. For RT-qPCR, 
1 µL of diluted cDNA was combined with 5 µL of SensiFAST Probe Hi-ROX Kit (Bioline, UK), 3.5 µL  dH2O, and 
0.5 µL of TaqMan Probe for gene expression or miRNA. Samples were prepared on a MicroAmp optical 96-well 
reaction plate as technical triplicates (Life Technologies, USA) and analysed using the QuantStudio 6 flex real-
time PCR system (Life Technologies, USA). Data was analysed using LinRegPCR (v2017.1), and presented as 
absolute expression of genetic material prior to amplification (N0). The N0 value is the raw fluorescent value and 
an indication of the expression.
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Cytokine assay. The quantities of IL-6 and TNF secreted by transfected bone marrow derived macrophages 
was determined using ELISA kits (BD Biosciences, USA) according to manufacturer’s instructions.
Statistical analysis. Results were analysed using Graphpad prism software (version 8). Comparisons 
between samples were made using one-way ANOVA with Tukey post hoc test. Differences were considered 
significant when P ≤ 0.05.
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